Valeant

I Dont Want To Get Rid Of My Psoriasis
Health

Valeant Stock Was Having a Pretty Good 2018—Until Today

By
June 18, 2018
Valeant Pharmaceuticals Offices Ahead Of Earnings Figures
Health

Valeant Is Changing Names—And Its Stock Is Soaring After a Much-Needed FDA Approval

By
May 8, 2018
Female Sex Pill
Health

Should ‘Female Viagra’ Have Ever Been Approved?

By
November 7, 2017
Cosmopolitan: Let's Talk About It Event
Finance

Valeant Is Paying to Get Rid of Its $1 Billion ‘Female Viagra’ Acquisition

By
November 7, 2017
Valeant CEO Joseph Papa. The stock soared Tuesday after a rosy forecast.
Finance

Valeant Stock Is Soaring After the Drugmaker Boosts Its Outlook

By
May 9, 2017
Perrigo Co. Chief Executive Officer Joe Papa Interview
Health

Why Valeant Stock Just Plunged Into the Single Digits

By
April 5, 2017
Bill Ackman herbalife
Finance

Bill Ackman Finally Apologizes for His ‘Huge Mistake’ With Valeant

By
March 29, 2017
Perrigo Co. Chief Executive Officer Joe Papa Interview
Finance

Valeant’s New CEO Joe Papa Has a $17 Billion Ultimatum

By
March 29, 2017
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Finance

Valeant’s Former CEO Is Suing the Company for 3 Million Allegedly Unpaid Shares

By
March 28, 2017
Bill Ackman herbalife
Finance

Bill Ackman Lost $7.7 Million Per Day on Valeant Stock

By
March 15, 2017
Trading At The NYSE As Valeant Shares Halted Ahead of News Announcement
Finance

Valeant’s Debt Refinance Will Go On Without Bill Ackman

By
March 14, 2017
Valeant Pharmaceuticals Offices Ahead Of Earnings Figures
Finance

Why Ackman’s Exit May Not Be the End of Valeant’s Stock Plunge

By
March 14, 2017
Key Speakers At The New York Times DealBook Conference
Finance

Valeant Stock Is Bringing Bill Ackman’s Hedge Fund Back From the Dead

By
February 17, 2017
Perrigo Co. Chief Executive Officer Joe Papa Interview
Finance

Valeant Just Made a Killing on a Series of Drug Deals

By
January 10, 2017
Valeant Pharmaceuticals International Inc's new chief executive Joseph Papa answers questions from shareholders during their annual general meeting in Laval
Finance

Here’s What Wall Street Has to Say About Valeant’s L’Oreal and Sanpower Deals

By
January 10, 2017

Most Popular